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ABSTRACT
Background Grip strength has consistently been found
to predict all-cause mortality rates. However, few studies
have examined cause-speciﬁc mortality or tested age
differences in these associations.
Methods In 1994, grip strength was measured in the
population-based Tromsø Study, covering the ages
50–80 years (N=6850). Grip strength was categorised
into ﬁfths, and as z-scores. In this cohort study, models
with all-cause mortality and deaths from speciﬁc causes
as the outcome were performed, stratiﬁed by sex and
age using Cox regression, adjusting for lifestyle-related
and health-related factors.
Results During 17 years of follow-up, 2338
participants died. A 1 SD reduction in grip strength was
associated with HR=1.17 (95% CI 1.12 to 1.22) for all-
cause mortality in a model adjusted for age, gender and
body size. This association was similar across all age
groups, in men and women, and robust to adjustment
for a range of lifestyle-related and health-related factors.
Results for deaths due to cardiovascular disease (CVD),
respiratory diseases and external causes resembled those
for all-cause mortality, while for cancer, the association
was much weaker and not signiﬁcant after adjustment
for lifestyle-related and health-related factors.
Conclusions Weaker grip strength was associated with
increased all-cause mortality rates, with similar effects on
deaths due to CVD, respiratory disease and external
causes, while a much weaker association was observed
for cancer-related deaths. These associations were similar
in both genders and across age groups, which supports
the hypothesis that grip strength might be a biomarker
of ageing over the lifespan.
INTRODUCTION
Grip strength is a simple measure used to indicate
overall muscle strength which has been shown to
have health-related prognostic value.1 2 Evidence
suggests grip strength declines from midlife
onwards3–6 and is a powerful predictor of future
disability, falls, morbidity and mortality.1 7–9 A sys-
tematic review and meta-analysis published in 2010
identiﬁed 23 publications which had examined the
association between grip strength and all-cause
mortality in community-dwelling populations.9
Effect estimates from 14 of these studies represent-
ing more than 50 000 participants were included in
a meta-analysis, producing an overall summary HR
of 1.7 for all-cause mortality when the weakest
quarter of grip strength was compared with the
strongest quarter.9 When meta-analyses were strati-
ﬁed by age, gender and length of follow-up, there
was some evidence to suggest that associations
between grip strength and all-cause mortality may
be higher in older age groups, stronger in males
compared with females, and in studies with
follow-up of <10 years, however, there was limited
statistical power to formally test these differences.9
Since the publication of this review, subsequent
studies have continued to ﬁnd that weaker grip
strength is associated with increased all-cause mor-
tality rates in a range of settings.10–13
Most studies of grip strength in middle and old
age have investigated associations with all-cause
mortality, and studies that have examined cause-
speciﬁc mortality are not as numerous.14–19
Furthermore, often such studies are only powered
to investigate broad groups of causes of death such
as cardiovascular disease (CVD) and cancer, and
have not been able to look at additional causes
such as ischaemic heart disease (IHD), respiratory
diseases and external causes. Recently, ﬁndings
from a study which had measures of grip strength
in almost 140 000 people aged 35–70 years from
17 countries were reported. This study found that
weak grip strength was related to increased rates of
all-cause mortality, cardiovascular mortality, myo-
cardial infarction and stroke, while no association
was found for cancer mortality.14 These ﬁndings of
an association between grip strength and cardiovas-
cular mortality and no association with cancer mor-
tality are consistent with those from a study of 1
million Swedish male adolescents aged 16–19 years
followed over a period of 24 years.19 These results,
of an association between grip strength and cardio-
vascular mortality and no association for cancer,
suggest a potential mechanistic explanation related
to the cardiovascular system,7 14 which should be
further explored.
Large-scale studies including objectively mea-
sured physical performance and strength are
lacking in Norway, with one exception; the Tromsø
Study, a longitudinal study with six follow-ups in
the period 1974–2008. Grip strength was object-
ively measured in 1994, in a sample of men and
women covering a wide range of ages.20 Our aim
was to investigate the associations of grip strength
with all-cause and cause-speciﬁc mortality (CVD,
stroke, IHD, cancer, respiratory diseases and exter-
nal causes) in men and women in this large general
Norwegian population. Low grip strength in ado-
lescents has been found to be associated with
increased suicide risk in young adulthood,19 but to
the best of our knowledge, our paper is the ﬁrst to
investigate the association between grip strength
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and the broader group of external causes of death. Another
novel aspect of our study was our aim to formally test whether
any associations varied by age and sex at strength assessment.
METHODS
Study population
The Tromsø Study is a longitudinal population-based multi-
purpose study focusing on lifestyle-related diseases, initiated in
1974 with surveys, inviting earlier participants as well as recruit-
ing new participants, repeated in 1979, 1986, 1994, 2001 and
2008.20 This study uses baseline data from the survey initiated
in 1994. At this time, all those men and women in the munici-
pality aged 25 years and above (n=37 558) were invited to par-
ticipate in phase I of the survey. All men aged 55–74 years, all
women aged 50–74 years and 5–10% random samples of other
birth cohorts aged 25–84 years were preselected to undergo a
more extensive phase II examination (10 542 participants)
which included grip strength measurements. The attendance
rate was 74% in men and 77% in women. In the current ana-
lysis, 6850 participants (58% women) aged 50–80 years at the
time of screening and with valid grip strength were included.
Participants outside this age range were excluded as there were
too few deaths among the 925 individuals below 50 years
(n=41), and there were few participants above 80 years (n=14).
The Regional Committee of Research Ethics recommended and
the Norwegian Data Inspectorate approved the study.
Assessment of grip strength
Grip strength of the non-dominant hand was measured in
bar in the Tromsø Study, wave four (1994–1995) using a
Martin vigorimeter. Each participant was allowed two attempts,
and the highest score registered was recorded and used in
analyses.
Ascertainment of mortality
Data on each participant were linked to death certiﬁcate data
from the Norwegian Cause of Death Registry, and participants
were followed from 1 January 1996 to 31 December 2012,
death or emigration, whichever occurred ﬁrst. Thus, follow-up
started ∼2 years after the time point of the health examination,
which was done to minimise the effect of reverse causation
from disease at baseline. Only 51 participants (0.7%) left the
study (died or emigrated) during the ﬁrst 2 years, before 1
January 1996. Participants had mean follow-up time of
14.4 years, and maximum 17.0 years, and mean age at the end
of follow-up was 77.5 years (minimum 51.7 and maximum
96.4 years). Causes of death were based on underlying cause of
death at the death recorded by a medical doctor on the certiﬁ-
cate and categorised using the International Classiﬁcation of
Diseases (ICD) V.10 and grouped as: cancer (C00-C97), CVD
(I00-I99), IHD (I20-I25), stroke (I60-I69), respiratory causes
( J00-J99) and external causes (V01-Y89) (such as accidents,
falls, injuries, poisoning, assault and other adverse events).
Covariates
Covariates known to be associated with grip strength and mor-
tality were selected a priori for inclusion as possible confoun-
ders. All these covariates were taken from the baseline study in
Tromsø 4 in 1994–1995. Height and weight were measured in
light clothing without shoes. Body mass index (BMI) was calcu-
lated as weight in kilograms divided by the square of height in
metres. Blood pressure was assessed three times after 2 min
seated rest with 1 min interval with an oscillometric digital auto-
mated device (Dinamap Vital Signs Monitor; Critikon Inc,
Tampa, Florida, USA21). The mean systolic blood pressure of
reading two and three was used. From non-fasting blood
samples, total cholesterol level (mmol/L) and triglycerides
(mmol/L) were analysed at the Department of Clinical
Chemistry, University Hospital of North Norway. The partici-
pants completed two self-administered questionnaires, one
before entering the study, and the other during the study. From
these questionnaires, data on health status were derived (poor,
not so good, good, very good), a history of heart attack, angina,
stroke, asthma or diabetes. Participants also provided informa-
tion on light physical activity (not sweating or out of breath)
and hard physical activity (sweating and/or out of breath) during
a typical week in the last year, and for each of the two variables
participants were categorised in four groups based on hours per
week in activity (none, less than one, one to two, three or
more). Participants were asked if they used blood pressure-
lowering drugs (currently, previously, but not now, never).
Participants were dichotomised as current cigarette smokers or
non-current cigarette smokers. Education was stratiﬁed into ﬁve
groups: primary (7–10 years), technical school/middle school,
high school diploma (3–4 years), college/university <4 years
and college/university 4 years or more.
Statistical methods
To allow investigation of variation in the association between
grip strength and mortality by age, participants were assigned to
one of the three age groups based on age at the time of grip
strength assessment: 50–59, 60–69 and 70–80 years.
Sex-speciﬁc quintiles for grip strength in each of these age
groups were created. Age-speciﬁc and gender-speciﬁc grip
strength z-scores were also created, which had a mean of 0 and
SD of 1.
In a ﬁrst set of analyses, Cox regression was used to assess the
associations between ﬁfths of grip strength and hazards of mor-
tality, with the strongest ﬁfth used as the reference category. In a
second set of analyses, the associations were assessed using age-
speciﬁc and gender-speciﬁc grip strength z-scores. In a third set
of analyses, the associations were modelled using grip strength
z-scores as natural cubic splines with three knots to allow for a
more ﬂexible analysis of grip strength on the continuous scale.
This approach allowed us to investigate deviation from linearity,
and test for evidence of thresholds. All three sets of analyses
examined associations of grip strength with all-cause and cause-
speciﬁc mortality rates. In all models, attained age was the time
scale, and thereby models were adjusted for age. In addition,
models were ﬁrst adjusted for sex and body size (height and
BMI) and then for all health-related and lifestyle-related factors.
To investigate differences in associations by age group, an age
group by grip strength interaction term was included in a subse-
quent stage of analyses. In the gender-adjusted model, gender
was treated as a covariate. The proportional hazards assumption
was checked using Schoenfeld residuals, and on the basis of
visual inspection of the estimated hazard function. No severe
violations of proportionality were observed. Stata SE V.14.0 was
used for the analyses.
RESULTS
Mean value for the absolute grip strength for the total study
population was 0.78 bar with SD 0.21, and 0.84 bar (SD 0.21)
in men and 0.73 bar (SD 0.20) in women. By age group, the
mean values in men were: 0.94 bar (SD 0.21) (50–59 years),
0.82 bar (SD 0.19) (60–69 years) and 0.70 bar (SD 0.17) (70–
80 years). Corresponding values in women were: 0.78 bar
(0.20), 0.70 bar (0.18) and 0.63 bar (0.15).
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Table 1 displays the baseline characteristics of the participants
stratiﬁed by ﬁfths of grip strength by gender. Those in the
higher grip strength categories had higher BMI, were younger,
reported better overall health, had less history of heart disease
and asthma, smoked less, were more physically active and had
higher education than those in the lower grip strength categories
(all p<0.05). Overall, there were 2338 deaths among the 6850
participants during follow-up, of which 35% of deaths were
caused by CVD (8% of which were stroke and 17% IHD), 35%
by cancer, 9% by respiratory diseases, 3% by external causes
(table 2) and 18% other causes. Regression models in tables 3
and 4 and in ﬁgure 1 were run on a slightly smaller sample with
no missing data on covariates (N=6601, with 2225 deaths). Of
these deaths, 776 were due to CVD (of which 183 were due to
stroke and 366 were due to IHD), 774 were due to cancer, 200
were due to respiratory diseases, 68 were due to external causes
and 407 were due to other causes. Minimally adjusted results
on the maximum available samples produced very similar results
(results not shown).
All-cause mortality
Grip strength was inversely associated with all-cause mortality
rates in men and women (table 3), with no grip strength by
gender interaction found when grip strength was modelled lin-
early (p=0.91); 1 SD lower grip strength was associated with an
HR of all-cause mortality of 1.17 (95% CI 1.12 to 1.22) in a
model adjusted for age, gender and body size, which was only
partially attenuated in the fully adjusted model (HR=1.12, 95%
CI 1.07 to 1.17). The spline models suggested a linear association
between grip and all-cause mortality rates in men, while in
women, there was some evidence that only grip strength below
the mean was associated with increased mortality rates (ﬁgure 1).
Weaker grip strength was associated with increased hazards of
mortality in all age groups (overall p<0.05; table 4), with no evi-
dence of a grip strength by age interaction (p=0.69; table 4).
Results were similar using grip in ﬁfths rather than z-scores (see
online supplementary appendix table A1).
Cardiovascular mortality
Weaker grip strength was associated with increased CVD mor-
tality rates (per 1 SD lower grip strength HR=1.21, 95% CI
1.12 to 1.30) in a model adjusted for age, sex and body size,
and this was not completely attenuated in the fully adjusted
model (HR=1.14, 95% CI 1.06 to 1.22) (table 4). The associ-
ation between grip strength and CVD mortality was similar in
men and women (p=0.98). Furthermore, the association
between grip strength and CVD mortality was similar across age
groups (grip strength by age interaction, p=0.84) (table 4).
Results were similar using grip in ﬁfths rather than z-scores (see
online supplementary appendix table A1). The spline models
indicated linear associations between grip strength and CVD
mortality (ﬁgure 1). Similar associations of grip strength with
stroke and IHD mortality were found (table 3).
Cancer mortality
Weaker grip strength was associated with increased cancer mor-
tality in the minimally adjusted model (per 1 SD lower grip
strength HR=1.07, 95% CI 1.00 to 1.16), but this was fully
attenuated in the fully adjusted model (HR=1.05, 95% 0.97,
1.13). While there was some evidence in basic models that grip
strength was associated with cancer mortality in men
(HR=1.11, 95% CI 1.00 to 1.29) but not in women
(HR=1.04, 95% CI 0.93 to 1.15), the grip strength by gender
interaction term was not signiﬁcant (p=0.46). However, after
adjustment for health-related and lifestyle-related factors, the
grip strength–cancer association was not signiﬁcant in either sex
(table 3, ﬁgure 1). Furthermore, there was evidence that the
association between grip strength and cancer mortality was only
signiﬁcant in the youngest age group (ie, 50–59 years;
HR=1.15, 95% CI 1.00 to 1.32), while in the older groups, the
association did not reach statistical signiﬁcance (table 4).
However, the interaction between grip strength and age group
was non-signiﬁcant (p=0.29; table 4). Results were similar
using grip in ﬁfths rather than z-scores (see online supplemen-
tary appendix table A1).
Respiratory and external causes of mortality
Weaker grip strength was signiﬁcantly associated with increased
respiratory disease mortality in the minimally adjusted model
(per 1 SD lower grip strength HR=1.35, 95% CI 1.16 to 1.57)
(table 3), and the HR did not differ between men and women
(p=0.69). The association was robust to adjustment for a range
of health-related factors (HR=1.23, 95% CI 1.06 to 1.44). For
external causes of death, a 1 SD lower grip strength was asso-
ciated with HR=1.44 (95% CI 1.13 to 1.84) in the minimally
adjusted model, and there was no signiﬁcant grip strength by
gender interaction (p=0.79). The association was robust to
further adjustment (HR=1.37, 95% CI 1.06 to 1.76). Numbers
of deaths due to respiratory diseases and external factors were
too small for age-speciﬁc analyses of these causes of death. See
ﬁgure 1 for a graphical illustration of the associations of grip
strength with deaths from respiratory diseases and external
causes.
Results for all-cause mortality, CVD mortality and cancer
mortality using grip in ﬁfths are reported in online
supplementary appendix table A1.
There were 162 participants reporting a history of stroke
(2.4%), and as a sensitivity analysis, we performed an additional
set of analyses in which these participants were excluded. This sen-
sitivity analysis provided results similar to those described above.
DISCUSSION
In this large population-based study of home-dwelling
Norwegians aged 50–80 years followed over 17 years including
2338 deaths, we found weaker grip strength to be associated
with signiﬁcantly higher rates of all-cause mortality in a stepwise
fashion. This association was similar across age groups and in
men and women. These associations were not fully explained by
adjustment for a range of lifestyle-related and health-related
factors. Results for deaths due to CVD, respiratory disease and
external causes resembled those for all-cause mortality, while
cancer mortality was only weakly associated with grip strength
in men, and this association was not signiﬁcant in fully adjusted
analyses.
The ﬁnding of an association between weaker grip strength
and higher rates of all-cause mortality is in line with ﬁndings
from previous reports.9–13 Our ﬁnding of similar associations
between grip strength and all-cause mortality across age groups
is in line with the few previous reports which have been able to
stratify analyses by age.14–16 19 22 23 Our ﬁnding of an equally
strong inverse association between grip strength and all-cause
mortality in men and women is also consistent with ﬁndings in
other studies.14 17
Analyses of grip strength and cause-speciﬁc mortality are less
numerous.14–19 Consistent with our ﬁndings, those six studies
which have explored cause-speciﬁc mortality previously have
found stronger grip to be associated with lower CVD mortality
rates,14–19 and those four studies which included men and
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women found the association to be similar in both genders.14–17
The two studies that had investigated stroke mortality found
similarly to us that this association was similar to the grip
strength—CVD association. The consistency across studies of
the inverse association between grip strength and CVD
mortality suggests potential mechanism acting on the cardiovas-
cular pathway. Increased grip strength has been found to be
associated with a more favourable cardiovascular risk factor
proﬁle,24 but the strong association found in our study was only
weakly attenuated after adjustment for a wide range of CVD
Table 1 Baseline characteristics of the Tromsø Study population, by grip strength fifths (gender and age specific)
N Total 1 (Lowest grip) 2 3 4 5 (Highest grip) Trend*
Men
Number of participants 2858 2858 593 562 627 514 562
Number of deaths 1253 1253 317 258 266 214 198
Mortality rate (95% CI)† 2858 38.6 (30.7 to 34.3) 43.6 (39.1 to 48.7) 34.4 (30.4 to 38.8) 31.1 (27.6 to 35.1) 30.1 (26.3 to 34.4) 24.4 (21.2 to 28.0) <0.001‡
Age 2858 62.0 (6.4) 63.3 (6.4) 63.0 (6.0) 62.4 (6.3) 62.8 (6.5) 62.0 (6.6) 0.001
Grip strength (bar) 2858 0.84 (0.21) 0.58 (0.12) 0.74 (0.08) 0.85 (0.09) 0.95 (0.10) 1.12 (0.15) <0.001
BMI (kg/m2) 2855 26.1 (3.4) 25.5 (3.7) 25.7 (3.4) 26.2 (3.2) 26.1 (3.1) 26.9 (3.3) <0.001
Height (cm) 2855 174.8 (6.0) 172.4 (6.8) 174.0 (6.9) 174.7 (6.4) 176.0 (6.5) 177.2 (6.0) <0.001
Systolic BP (mm Hg) 2857 146.7 (20.8) 146.0 (21.1) 145.2 (20.7) 147.5 (21.0) 146.1 (20.3) 148.7 (20.9) 0.019
Cholesterol (mmol/L) 2851 6.6 (1.2) 6.6 (1.2) 6.7 (1.2) 6.6 (1.2) 6.5 (1.1) 6.6 (1.2) 0.475
Triglycerides (mmol/L) 2847 1.8 (1.1) 1.7 (1.1) 1.8 (1.0) 1.8 (1.2) 1.7 (0.9) 1.9 (1.1) 0.158
Poor/not good health, % 2854 43 52 46 40 43 35 <0.001
History of heart attack, % 2848 10 10 11 10 13 6 0.006
History of angina, % 2847 12 16 13 11 12 9 0.017
History of stroke, % 2846 3 6 3 2 4 2 <0.001
History of asthma, % 2846 7 7 9 7 7 7 0.614
History of diabetes, % 2846 4 5 2 4 4 3 0.068
Blood pressure medication, % 2841 20 21 18 21 21 17 0.313
Smoke cigarettes, % 2857 31 35 36 33 29 24 <0.001
No light physical activity, % 2841 26 29 28 23 24 23 0.034
No hard physical activity, % 2827 73 80 74 68 74 71 <0.001
Low education, % 2847 48 57 50 49 44 38 <0.001
Women
Number of participants 3992 3992 843 880 732 787 750
Number of deaths 1085 1085 281 268 181 180 175
Mortality rate (95% CI)† 3992 18.0 (16.9 to 19.1) 22.8 (20.3 to 25.6) 20.4 (18.1 to 23.0) 16.1 (13.9 to 18.6) 14.9 (12.9 to 17.3) 15.1 (13.0 to 17.5) <0.001‡
Age 3992 60.8 (7.4) 61.2 (7.4) 61.1 (7.4) 60.6 (7.2) 60.5 (7.3) 60.2 (7.5) 0.001
Grip strength (bar) 3992 0.73 (0.20) 0.47 (0.11) 0.65 (0.06) 0.74 (0.06) 0.83 (0.07) 1.00 (0.12) <0.001
BMI (kg/m2) 3984 26.1 (4.4) 26.1 (4.8) 25.7 (4.5) 26.0 (4.3) 26.3 (4.0) 26.4 (4.4) 0.011
Height (cm) 3986 161.6 (6.2) 160.5 (6.3) 161.1 (6.4) 161.5 (6.3) 161.9 (5.8) 163.1 (5.8) <0.001
Systolic BP (mm Hg) 3991 144.8 (23.6) 142.8 (22.8) 144.7 (23.9) 145.5 (23.9) 145.0 (24.2) 146.3 (23.0) 0.006
Cholesterol (mmol/L) 3998 7.0 (1.3) 7.1 (1.3) 7.0 (1.3) 7.0 (1.2) 6.9 (1.2) 6.9 (1.3) 0.007
Triglycerides (mmol/L) 3986 1.6 (1.0) 1.6 (0.9) 1.6 (0.9) 1.6 (1.1) 1.6 (1.0) 1.6 (0.9) 0.692
Poor/not good health, % 3986 50 69 49 45 45 39 0.178
History of heart attack, % 3979 3 4 2 2 4 2 0.005
History of angina, % 3983 7 10 6 5 6 5 0.001
History of stroke, % 3976 2 4 2 1 1 0.5 <0.001
History of asthma, % 3975 9 11 10 7 7 7 0.008
History of diabetes, % 3976 3 3 4 2 2 3 0.294
Blood pressure medication, % 3975 17 19 17 16 17 17 0.609
Smoke cigarettes, % 3988 30 34 33 30 28 27 0.005
No light physical activity, % 3985 27 34 30 25 23 22 <0.001
No hard physical activity, % 3948 86 91 86 84 84 82 <0.001
Low education, % 3961 61 69 63 59 59 56 <0.001
Figures are means (SD), unless stated otherwise.
For brevity, descriptive statistics for only the ‘highest risk’ category of each categorical covariate are presented. Categorisations used are as follows: self-reported health status (poor, not
so good, good, very good); history of heart attack (yes, no); history of angina (yes, no); history of stroke (yes, no); history of asthma (yes, no); history of diabetes (yes, no); use of blood
pressure-lowering drugs (currently, previously but not now, never); current cigarette smokers (yes, no); light physical activity such as not sweating or out of breath during a typical week
in the last year (none, less than one, one to two, three or more); hard physical activity such as sweating and/or out of breath during a typical week in the last year (none, less than one,
one to two, three or more); education (primary (7–10 years), technical school/middle school, high school diploma (3–4 years), college/university <4 years, college/university 4 years or
more).
*p Values for trend based on linear regression for the continuous variables, and logistic regression for the dichotomous ones. Grip in fifths treated as a continuous variable in the
regression models.
†Mortality rate per 1000 (95% CI).
‡The trend across mortality rates calculated using Poisson regression adjusted for age and sex.
BMI, body mass index; BP, blood pressure.
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risk factors. Another important ﬁnding in support of the cardio-
vascular pathway is that grip strength has been found to be an
equally important prognostic factor as systolic blood pressure
regarding CVD mortality risk.14
In our study, the association between grip strength and cancer
mortality was weaker than for CVD, and restricted to men.
Results for grip strength and cancer mortality are not consistent
in the literature. In line with our ﬁndings, Sasaki et al15 and
Gale et al17 found stronger grip to be associated with lower
cancer mortality in men only. Another study of US men also
found stronger grip to be associated with lower cancer mortality
risk.18 The other two studies reported no signiﬁcant associ-
ation,16 19 and Leong et al14 reported the unexpected ﬁnding of
a protective effect of low grip strength on cancer mortality.
Potential explanations for the inconsistent results regarding
cancer mortality might be due to power issues and differences
Table 2 Number of deaths and mortality rate (per 1000 person-years) by cause of death, gender and age group
Men and
women Men Women
50–80 years
(N=6601)
50–80 years
(N=2744)
50–59 years
(N=987)
60–69 years
(N=1259)
70–80 years
(N=498)
50–80 years
(N=3857)
50–59 years
(N=1860)
60–69 years
(N=1405)
70–80 years
(N=592)
Number of deaths
Total mortality 2225 1189 204 597 388 1036 218 456 362
Cardiovascular 776 423 71 201 151 353 44 148 161
Stroke 183 81 5 49 27 102 11 43 48
IHD 366 228 48 92 88 138 18 61 59
Cancer 774 412 86 219 107 362 125 168 69
Respiratory 200 115 15 55 45 85 17 39 29
External 68 39 – – – 29 – – –
Mortality rate
Total mortality 23.3 31.9 13.5 35.6 73.0 17.7 7.3 21.8 48.5
Cardiovascular 8.1 11.4 4.7 12.0 28.4 6.0 1.5 7.1 21.6
Stroke 1.9 2.2 0.3 2.9 5.1 1.7 0.4 2.1 6.4
IHD 3.8 6.1 3.2 5.5 16.5 2.4 0.6 2.9 7.9
Cancer 8.1 11.1 5.7 13.1 20.1 6.2 4.2 8.0 9.2
Respiratory 2.1 3.1 1.0 3.3 8.5 1.5 0.6 1.9 3.9
External 0.7 1.0 – – – 0.5 – – –
Deaths due to external causes are only presented for 50–80 years and not age specific due to small numbers. Study sample has non-missing values for all included covariates (age, sex,
BMI, systolic blood pressure, total cholesterol, triglycerides, self-reported general health status, self-reported history of heart attack, stroke, angina, asthma and diabetes, self-reported
blood pressure treatment, smoking, leisure-time physical activity and education).
BMI, body mass index; IHD, ischaemic heart disease.
Table 3 HR (95% CI) for all-cause and cause-specific mortality per 1 SD reduction in grip strength
Men and women Men Women Gender interaction
Number of participants 6601 2744 3857
Cause of death ( number of deaths)
Model 1*
Total mortality (2225) 1.17 (1.12 to 1.22) 1.18 (1.11 to 1.26) 1.16 (1.09 to 1.23) 0.91
Cardiovascular (776) 1.21 (1.12 to 1.30) 1.22 (1.10 to 1.36) 1.19 (1.07 to 1.33) 0.98
Stroke (183) 1.26 (1.08 to 1.47) 1.35 (1.06 to 1.71) 1.22 (0.99 to 1.49) 0.76
IHD (366) 1.18 (1.06 to 1.32) 1.17 (1.02 to 1.35) 1.20 (1.01 to 1.43) 0.59
Cancer (774) 1.07 (1.00 to 1.15) 1.11 (1.00 to 1.29) 1.04 (0.93 to 1.15) 0.46
Respiratory (200) 1.35 (1.16 to 1.57) 1.34 (1.10 to 1.63) 1.39 (1.11 to 1.74) 0.69
External causes (68) 1.44 (1.13 to 1.84) 1.37 (0.98 to 1.91) 1.51 (1.05 to 2.17) 0.79
Model 2†
Total mortality (2225) 1.12 (1.07 to 1.17) 1.13 (1.06 to 1.20) 1.11 (1.04 to 1.19) 0.85
Cardiovascular (776) 1.14 (1.06 to 1.23) 1.14 (1.03 to 1.27) 1.15 (1.03 to 1.29) 0.68
Stroke (183) 1.19 (1.02 to 1.39) 1.20 (0.95 to 1.53) 1.18 (0.95 to 1.45) 0.93
IHD (366) 1.11 (1.00 to 1.24) 1.11 (0.96 to 1.28) 1.15 (0.96 to 1.37) 0.41
Cancer (774) 1.05 (0.97 to 1.13) 1.09 (0.98 to 1.21) 1.03 (0.92 to 1.15) 0.40
Respiratory (200) 1.23 (1.06 to 1.44) 1.32 (1.06 to 1.65) 1.22 (0.96 to 1.55) 0.48
External causes (68) 1.37 (1.06 to 1.76) 1.30 (0.92 to 1.83) 1.47 (0.99 to 2.17) 0.79
Age 50–80 years at baseline.
*Model 1. Adjusted for age, sex and body size (BMI and height).
†Model 2. Adjusted for age, sex and body size (BMI and height)+systolic blood pressure, total cholesterol, triglycerides, self-reported general health status, self-reported history of heart
attack, stroke, angina, asthma and diabetes, self-reported blood pressure treatment, smoking, leisure-time physical activity and education.
BMI, body mass index; IHD, ischaemic heart disease.
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in study designs. Further studies should investigate the associ-
ation by cancer subtype.
We had sufﬁcient power to study the association between grip
strength and mortality from respiratory diseases, and our results
suggest that weak muscle strength is associated with deaths from
respiratory diseases in men and women. To our knowledge,
only two other studies have investigated this, and their results
are in line with ours.16 17 In contrast with these ﬁndings, no
association between grip strength and hospital admission with
respiratory illness was reported in a recent study.14 However,
this could be due to differences in study outcome, that is,
hospital admission versus mortality. Another study from Japan
reported an association between grip strength and death due to
pneumonia, one important cause of respiratory death.15
Our ﬁnding of an association between weak grip strength and
increased rates of death due to external causes is novel, and we
are not aware of other studies investigating this. Suicide, a sub-
category of external causes, was studied in male adolescents in a
Swedish study, and here those in the lowest tenth of grip
strength were found to have higher rates of mortality due to
suicide.19 It was suggested that physically weaker men might be
more psychologically vulnerable, but the mechanisms are not
Table 4 HR for all-cause and cause-specific mortality per 1 SD reduction in grip strength, by age at grip assessment
Cause of death (number of deaths in ages: 50–59, 60–69, 70–80 years) Age 50–59 Age 60–69 Age 70–80 Age interaction
Model 1*
Total mortality (422, 1053, 750) 1.21 (1.10 to 1.34) 1.18 (1.10 to 1.25) 1.13 (1.05 to 1.22) 0.69
Cardiovascular (115, 349, 312) 1.19 (0.98 to 1.45) 1.22 (1.09 to 1.36) 1.24 (1.10 to 1.39) 0.84
Cancer (211, 387, 176) 1.15 (1.00 to 1.32) 1.06 (0.96 to 1.18) 0.98 (0.84 to 1.16) 0.29
Model 2†
Total mortality (422, 1053, 750) 1.14 (1.03 to 1.26) 1.13 (1.06 to 1.20) 1.07 (0.99 to 1.16) 0.61
Cardiovascular (115, 349, 312) 1.14 (0.94 to 1.39) 1.14 (1.02 to 1.28) 1.16 (1.02 to 1.31) 0.87
Cancer (211, 387, 176) 1.11 (0.96 to 1.27) 1.04 (0.93 to 1.15) 0.97 (0.82 to 1.14) 0.32
Number of participants: 2847 in ages 50–69 years, 2664 in ages 60–69 years and 1090 in ages 70–80 years.
*Model 1. Adjusted for age, sex and body size (BMI and height).
†Model 2. Adjusted for age, sex and body size (BMI and height)+systolic blood pressure, total cholesterol, triglycerides, self-reported general health status, self-reported history of heart
attack, stroke, angina, asthma and diabetes, self-reported blood pressure treatment, smoking, leisure-time physical activity and education.
BMI, body mass index.
Figure 1 Grip z-scores and mortality HRs with 95% CIs (shaded areas) for men (blue solid lines) and women (red dashed lines). Estimated in Cox
regression with grip z-scores modelled as natural cubic splines with three knots. Z-score 0 is reference. *A is minimally adjusted for age and body
size (BMI and height); *B is fully adjusted for age and body size (BMI and height)+systolic blood pressure, total cholesterol, triglycerides,
self-reported general health status, self-reported history of heart attack, stroke, angina, asthma and diabetes, self-reported blood pressure treatment,
smoking, leisure-time physical activity and education. BMI, body mass index; CVD, cardiovascular disease.
Strand BH, et al. J Epidemiol Community Health 2016;70:1214–1221. doi:10.1136/jech-2015-206776 1219
Other topics
fully understood. In our study, suicide constituted only 8% of
the deaths due to external causes, and results were similar when
deaths due to external causes were examined having excluded
those due to suicide (results not shown). The absence of an
association between grip strength and the risk of injury from
falls (another subcategory of deaths due to external causes in
our study) was surprising to the authors in another study.14 A
large share of deaths due to external causes in the age group we
have studied are falls related, about one in three for ages above
75 years and one in four in the age group 70–74 years.25 Thus,
our ﬁndings contrast those of the other study,14 and this diver-
gence could be due to the relatively young age in the other
study (39–74 years at the end of follow-up) compared with our
participants (52–96 years at the end of follow-up). It could also
be due to differences in study outcome, that is, hospital admis-
sion versus mortality.
Most studies on grip strength and cause-speciﬁc mortality
have been performed among older populations, but associations
have also been shown for grip strength assessed at younger
ages19 26 and middle age.9 13 16 Our results of similar associa-
tions between grip strength and all-cause mortality and CVD
mortality in midlife and old age are in line with results from
Japan16 and the USA.18 Studies restricted to all-cause mortality
also show similar association with mortality, whether grip was
measured in midlife or old age.9
Our ﬁnding that grip strength is linked to deaths from diseases
that are strongly associated with ageing in our study, such as
CVD, stroke and respiratory diseases, is consistent with the
explanation that grip strength is a marker of underlying ageing
and disease processes. The strong association with deaths due to
external causes, such as falls, is also likely to be connected to the
ageing process, for example, decreasing reaction time and
reduced postural control. Thus, these ﬁndings suggest that weak
grip strength is a marker for advanced biologic age and poor
overall health. However, our results were robust and not fully
explained by adjustment for a range of health-related factors,
which suggests that poor overall health does not fully explain our
ﬁndings. Furthermore, our consistent ﬁndings across all age
groups, including the youngest age group, suggest that clinically
manifest conditions are unlikely to provide the whole explan-
ation. It suggests that weak grip strength may indicate underlying
ageing and disease processes even prior to their clinical manifest-
ation and thus may be a useful early sentinel of later life risk.
The main strengths of the present population-based study are
the long follow-up time and the large sample size and high
number of deaths, with sufﬁcient statistical power to perform
cause-speciﬁc analyses stratiﬁed by gender and age groups. The
Cause of Death Registry has a near-complete coverage and the
data quality is good.27 Another strength is our novel ﬁnding of
an association between grip strength and mortality from exter-
nal causes, which we were able to show was not driven by the
association between grip strength and suicide, which has previ-
ously been reported.19 A limitation of our study is also related
to study size, as it is underpowered to break down the rather
broad group of ‘external causes’ into ﬁner subgroups. Another
limitation is our use of a single measurement of grip strength,
whereby we were unable to study change in grip strength and its
association with mortality, which has been reported previ-
ously.28 As in most observational studies, there is also the possi-
bility of unmeasured confounding, which may account for the
relationship between grip strength and mortality. In our study,
we report age-speciﬁc and gender-speciﬁc grip strength z-scores;
therefore, the age and gender by grip interactions are based on
mortality HRs associated with a 1 unit z-score change within
each combination of age group and sex. If the grip strength dis-
tribution varied markedly between groups, for example,
between age groups, a 1 z-score unit change would mean a
quite different absolute change in grip strength for young and
old, which could affect interpretation of results. While the SD
was somewhat smaller in the older age group, it was similar in
both genders, and when an additional set of analyses were run
using absolute values of grip measured in bar, these gave results
similar to the analyses using z-scores (results not shown).
In conclusion, weaker grip strength was signiﬁcantly asso-
ciated with increased rates of all-cause mortality and deaths due
to a range of causes, including CVD, stroke, IHD and respira-
tory diseases. A novel ﬁnding was the association between
weaker grip strength and deaths due to external causes. These
associations were similar in both genders and across age groups,
which supports the hypothesis that grip strength might be a
useful biomarker of ageing over the lifespan.
What is already known on this subject
▸ Most studies of grip strength in middle and old age have found
a protective effect of high grip strength on all-cause mortality.
▸ Studies that have examined cause-speciﬁc mortality are not
as numerous, and there is a lack of studies that have
investigated age differences in these associations.
▸ Often studies have been powered only to investigate broad
groups of causes of death such as cardiovascular disease
and cancer, and have not been able to look at additional
causes such as ischaemic heart disease, respiratory diseases
and external causes.
What this study adds
▸ In line with previous studies, weaker grip strength was
associated with increased rates of all-cause mortality and
mortality due to cardiovascular disease (CVD) and
respiratory diseases.
▸ One study has reported weaker grip strength in adolescence
to be associated with increased rates of death from suicide
among men, but our study is the ﬁrst to report an
association of grip strength with mortality due to a broader
range of external causes in both sexes across different age
groups.
▸ A much weaker association was observed for cancer-related
deaths than for all-cause and CVD mortality.
▸ These associations were similar in both genders and across
age groups, which supports the hypothesis that grip strength
might be a biomarker of ageing over the lifespan.
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